Stockreport

Merck Trial Wins Shape Oncology And HIV Prospects For Investors [Yahoo! Finance]

Merck & Company, Inc. (new)  (MRK) 
Last merck & company, inc. (new) earnings: 4/28 06:45 am Check Earnings Report
US:NYSE Investor Relations: investors.merck.com/home/default.aspx
PDF Merck (NYSE:MRK) reported a series of positive late stage clinical trial results for oncology and HIV therapies, including new Phase 3 data for KEYTRUDA and WELIREG reg [Read more]